PubRank

Wenjian Yang

Author PubWeight™ 80.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009 10.54
2 Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 2011 4.93
3 Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 2004 4.16
4 Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009 3.71
5 Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA 2009 2.72
6 Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res 2011 2.52
7 Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]. J Clin Oncol 2008 2.51
8 Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol 2008 2.29
9 Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol 2009 2.20
10 Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Blood 2012 1.90
11 Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia. Blood 2008 1.89
12 Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst 2013 1.81
13 Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc 2013 1.80
14 Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat Genet 2003 1.79
15 Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood 2008 1.79
16 Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood 2011 1.67
17 PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Hum Mol Genet 2012 1.66
18 Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell 2005 1.58
19 PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet 2014 1.49
20 Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004 1.48
21 Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics. J Clin Invest 2005 1.46
22 Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet 2013 1.45
23 ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 2012 1.39
24 In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile. PLoS Med 2008 1.37
25 Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells. Nat Med 2011 1.34
26 Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol 2005 1.20
27 Genome-wide study of methotrexate clearance replicates SLCO1B1. Blood 2012 1.17
28 Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients. Clin Cancer Res 2012 1.15
29 C-reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis. Pediatrics 2005 1.13
30 Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood 2003 1.10
31 The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. J Natl Cancer Inst 2008 1.04
32 Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. Hum Mol Genet 2007 1.01
33 Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis. Blood 2004 0.98
34 CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. J Clin Oncol 2008 0.96
35 Lymphoid gene expression as a predictor of risk of secondary brain tumors. Genes Chromosomes Cancer 2005 0.94
36 Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment. Blood 2005 0.93
37 Evidence for age as a modifier of genetic associations for lipid levels. Ann Hum Genet 2011 0.92
38 Combination of early perinatal factors to identify near-term and term neonates for neuroprotection. J Perinatol 2005 0.91
39 Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes. Pharmacogenomics 2014 0.89
40 Concentrations and health risks of lead, cadmium, arsenic, and mercury in rice and edible mushrooms in China. Food Chem 2013 0.89
41 Global gene expression as a function of germline genetic variation. Hum Mol Genet 2005 0.83
42 Inter-individual variation of several cytochrome P450 2D6 splice variants in human liver. Biochem Biophys Res Commun 2005 0.81
43 Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia. Pharmacogenet Genomics 2008 0.81
44 Concordant gene expression in leukemia cells and normal leukocytes is associated with germline cis-SNPs. PLoS One 2008 0.80
45 Screening for inter-individual splicing differences in human GSTM4 and the discovery of a single nucleotide substitution related to the tandem skipping of two exons. Gene 2006 0.79
46 Chemical composition and synergistic antioxidant activities of essential oils from Atractylodes macrocephala and Astragalus membranaceus. Nat Prod Commun 2013 0.77
47 Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles. Colloids Surf B Biointerfaces 2010 0.76
48 Expression arrays illuminate a way forward for mantle cell lymphoma. Cancer Cell 2003 0.75
49 Efficacy and safety of tolazoline for treatment of severe hypoxemia in extremely preterm infants. Pediatrics 2002 0.75
50 Genetics of pleiotropic effects of dexamethasone. Pharmacogenet Genomics 2017 0.75
51 Neurobiologic risk score and long-term developmental outcomes of premature infants, birth weight less than 1,250 grams. J Med Assoc Thai 2002 0.75